Sellas Life Sciences Group, Inc. (SLS) SEC Filings — 2024
19 SEC filings for Sellas Life Sciences Group, Inc. (SLS) in 2024.
Filings
- SELLAS Life Sciences Group Files 8-K — 8-K · Dec 10, 2024
- SELLAS Life Sciences Group 10-Q Filing — 10-Q · Nov 13, 2024
- Sellas Life Sciences Group, Inc. SC 13G/A Filing — SC 13G/A · Nov 8, 2024
- SELLAS Life Sciences Group Enters Material Definitive Agreement — 8-K · Oct 4, 2024
- SELLAS Life Sciences Group Files Q2 2024 10-Q — 10-Q · Aug 13, 2024
- SELLAS Life Sciences Secures $50M Financing for GPS Commercialization — 8-K · Aug 1, 2024
- SELLAS Life Sciences Group Files 8-K on Shareholder Vote Matters — 8-K · Jun 21, 2024
- SELLAS Life Sciences Group, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 14, 2024
- SELLAS Life Sciences Group Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 29, 2024
- SELLAS Life Sciences Group, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 28, 2024
- SELLAS Life Sciences Closes $15M Public Offering — 8-K · Mar 28, 2024
- SELLAS Life Sciences Group Files 8-K — 8-K · Mar 15, 2024
- SELLAS Life Sciences Closes $20M Public Offering — 8-K · Mar 11, 2024
- SELLAS Life Sciences Appoints New CMO, Dr. Stergiou — 8-K · Mar 8, 2024
- SELLAS Life Sciences Closes $15M Public Offering — 8-K · Mar 5, 2024
- SELLAS Life Sciences Faces Nasdaq Delisting Warning — 8-K · Feb 16, 2024
- Highbridge Capital Discloses 4.9% Stake in SELLAS Life Sciences — SC 13G · Feb 7, 2024
- SELLAS Life Sciences Reports Material Definitive Agreement — 8-K · Jan 8, 2024
- SELLAS Life Sciences Terminates Material Agreement — 8-K · Jan 3, 2024